Wells Fargo on Soleno Therapeutics Inc. (SLNO): 'We Think Shares Should Trade Up at Least +20% on ACAD Failure'

Go back to Wells Fargo on Soleno Therapeutics Inc. (SLNO): 'We Think Shares Should Trade Up at Least +20% on ACAD Failure'
Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) Delayed: 28.24 -0.14 (0.49%)
Previous Close $28.38    52 Week High $42.49 
Open $28.26    52 Week Low $16.64 
Day High $28.43    P/E N/A 
Day Low $27.90    EPS $-0.42 
Volume 1,062,579       

(NASDAQ: SLNO) Delayed: 53.01 --0 (-0%)
Previous Close $53.01    52 Week High
Open $53.01    52 Week Low
Day High $53.01    P/E N/A 
Day Low $53.01    EPS
Volume 122,645